Touch imprint cytological analysis of sentinel lymph nodes for detecting axillary metastases in patients with breast cancer

British Journal of Surgery

Volumn 86, Issue 10, 1999, Pages 1346-1348

  Ratanawichitrasin, A ^a,b   Biscotti, C V ^a   Levy, L ^a   Crowe, J P ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

DISULFINE BLUE; EOSIN; HEMATOXYLIN; ISOSULFAN BLUE; PARAFFIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER CYTODIAGNOSIS; CANCER SCREENING; COMPARATIVE STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; FEMALE; HUMAN; HUMAN TISSUE; INTRAOPERATIVE PERIOD; LYMPH NODE BIOPSY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PATHOLOGIST; PRIORITY JOURNAL; PROSPECTIVE STUDY;

AXILLA; BIOPSY; BREAST NEOPLASMS; FEMALE; HUMANS; LYMPH NODES; MIDDLE AGED; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 0032819249     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2168.1999.01212.x     Document Type: Article

References (11)

1. Morris DL, Moore J, Thompson H, Keighley MRB. Peroperative lymph node imprint cytology for staging gastric carcinoma. Br J Surg 1982; 69: 282 (Abstract).
2. Chang MC, Chen RD, Ho WL. Intraoperative cytology: the use of Liu's stain for immediate diagnosis. Chung Hua I Hsueh Tsa Chih 1993; 51: 368-75.
3. Rimsten A, Johansson H, Stenkvist B. Peroperative diagnosis of axillary lymph nodes in cancer of the breast. Surg Gynecol Obstet 1974; 139: 551-4.
4. Adami HO, Graffman S, Johansson H, Rimsten A. Survival and recurrences five years after selective treatment for breast carcinoma. Br J Cancer 1978; 38: 624-30.
5. Quill DS, Leahy AL, Lawler RG, Finney RD. Lymph node imprint cytology for the rapid assessment of axillary node metastases in breast cancer. Br J Surg 1984; 71: 454-5.
6. Fisher CJ, Boyle S, Burke M, Price AB. Intraoperative assessment of nodal status in the selection of patients with breast cancer for axillary clearance. Br J Surg 1993; 80: 457-8.
7. Hadjiminas DJ, Burke M. Intraoperative assessment of nodal status in the selection of patients with breast cancer for axillary clearance. Br J Surg 1994; 81: 1615-16.
8. Ratanawichitrasin A, Levy L, Myles J, Crowe JP. Experience with lymphatic mapping in breast cancer using isosulfan blue dye. J Womens Health 1997; 7: 873-7.
9. Pickren JW. Significance of occult metastases. A study of breast cancer. Cancer 1961; 14: 1266-71.
10. Clare SE, Sener SF, Wilkens W, Goldschmidt R, Merkel D, Winchester DJ. Prognostic significance of occult lymph node metastases in node-negative breast cancer. Ann Surg Oncol 1997; 4: 447-51.
11. Giuliano AE, Dale PS, Turner RR, Morton DL, Evans SW, Krasne DL. Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg 1995; 222: 394-401.